Rapid Fire Sessions

Thursday 5.00 pm-6.00 pmMelbourne Room

Rapid Fire Session 1

Chair(s): Fabian Lerner (Argentina); TBA; Henny Beckers (Netherlands);

  • 5.00-5.05
    Spontaneous normal tension glaucoma in aged marmosets
    Takayuki Harada (Japan)
  • 5.05-5.10
    Bimatoprost Sustained-Release Implant for Lowering Intraocular Pressure: Long-Term Efficacy and Patient-Reported Outcomes
    Randy au Craven (United States)
  • 5.10-5.15
    Efficacy of A Deep Learning System for Detecting Glaucomatous Optic Neuropathy based on Color Fundus Photographs
    Mingguang He (China)
  • 5.15-5.20
    In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis
    Cynthia Yu-Wai-Man (United Kingdom)
  • 5.20-5.25
    Combined Optical Coherence Tomography and Visual Field Endpoints to Improve Future Glaucoma Clinical Trials
    Zhichao Wu (Australia)
  • 5.25-5.30
    Progression in Perimetrically Normal Eyes of Open-angle Glaucoma Patients with Unilateral Visual Field Loss: An Eight-year-follow-up Study
    Xiang Fan (China)
  • 5.30-5.35
    Interim results of a prospective, randomized phase 2 study evaluating the safety and efficacy of Travoprost Intraocular Implants
    Robert Edward Ang (Philippines)
  • 5.35-5.40
    Development and Validation of a Deep Learning Classifier to Detect Gonioscopic Angle Closure Based on Anterior Segment OCT Images
    Benjamin Xu (United States)
  • 5.40-5.45
    Wound healing and its potential biomarkers in human tear after trabeculectomy
    Natalia Volkova (Russian Federation)

Friday 5.00 pm-6.00 pmMelbourne Room

Rapid Fire Session 2

Chair(s): Ivan Goldberg (Australia); Parul Ichhpujani (India); Eddie Kgao Legodi (South Africa);

  • 5.00-5.05
    XEN Gel Stent Surgery in Patients with Open Angle Glaucoma: Two-Year Results
    Alice Di Domenico (Italy)
  • 5.05-5.10
    Outcomes of combined trabeculotomy with trabeculectomy in children with Aniridia and secondary glaucoma.
    Nkechinyere Judith Uche (India)
  • 5.10-5.15
    Trabecular Micro-Bypass with Cataract Surgery for Patients with Glaucoma: A Systematic Review and Meta-Analysis
    Nathan Kerr (Australia)
  • 5.15-5.20
    Comparison of bleb morphology by conjunctival incision after trabeculectomy
    Hailong Huang (Japan)
  • 5.20-5.25
    Multicenter, randomized study of a Schlemm’s canal microstent for reduction of IOP in primary open angle glaucoma (The HORIZON Trial)
    Cathleen McCabe (United States)
  • 5.25-5.30
    Real World MIGS: Australian & New Zealand experience of > 1000 Hydrus Microstent implants with 1 to 3 year follow up.
    Ashish Agar (Australia)
  • 5.30-5.35
    Post-operative outcomes of revision surgery for failed XEN Implants at a UK tertiary eye centre
    Emma Linton (United Kingdom)
  • 5.35-5.40
    Ab interno gel implant for the treatment of refractory glaucoma: results from the International Glaucoma Surgery Registry (IGSR)
    Nathan Kerr (Australia)
  • 5.40-5.45
    Lens Extraction with or without Goniosynechialysis in Primary Angle Closure Disease for angle parameters assessment.
    Jyoti Shakrawal (India)
  • 5.45-5.50
    Risk factors for corneal endothelial cell loss after trabeculectomy with mitomycin C
    Tomomi Higashide (Japan)
  • 5.50-5.55
    Goniowash: a new surgical approach combined with cataract surgery to lower intraocular pressure in pseudoexfoliation syndrome.
    Van Tao Tran (Switzerland)


Please contact our Professional Congress Organizer MCI for all your WGC-2019 questions

MCI Amsterdam
Schipluidenlaan 4
1062 HE Amsterdam
The Netherlands